Trial Profile
A prospective study to evaluate the efficacy of bevacizumab intravitreal injection in patients with retinopathy of prematurity
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Apr 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Retinopathy of prematurity
- Focus Therapeutic Use
- 20 Apr 2016 New trial record